SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

SVB Leerink Maintains Outperform on Alexion Pharmaceuticals, Lowers Price Target to $150

SVB Leerink maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and lowers the price target from $156 to $150.

Benzinga · 05/07/2020 12:50

SVB Leerink maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Outperform and lowers the price target from $156 to $150.